RIYADH: British drugmaker GlaxoSmithKline is currently Saudi Arabia’s sole supplier of an H1N1 flu vaccine but the Kingdom may include other firms for the supply of a nationwide inoculation campaign, the Health Ministry said.

Saudi Arabia’s vaccination campaign was launched on Saturday and will first focus on pilgrims and health workers.

“For the moment, the only vaccine that has been authorized is the GlaxoSmithKline vaccine Pandemrix,” Health Ministry spokesman Khaled Mirghalani told Reuters. “We will in the future get vaccines from other clients, from other companies, as soon as they get approved by the SFDA (Saudi Food and Drug Authority).”